Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1977 Jul 23;2(6081):218–220. doi: 10.1136/bmj.2.6081.218

Circulating immune complexes in patients with breast cancer.

K Hoffken, I D Meredith, R A Robins, R W Baldwin, C J Davies, R W Blamey
PMCID: PMC1631338  PMID: 884444

Abstract

In a retrospective study in women with breast cancer circulating immune complex levels were measured by radioimmunoprecipitation with 125I-Clq. Before operation all the patients showed plasma immune complex levels significantly higher than those in controls. Twelve months after mastectomy patients identified clinicopathologically as having a good prognosis had almost normal levels of immune complexes. By contrast, patients with detectable dissemination on diagnosis or those who died within 22 months after mastectomy had significantly raised plasma levels. The tumour-specific nature of the immune complexes detected remains to be shown and suggestions about the applicability of this test not only for prognosis but also for monitoring the course of malignant diseases need to be confirmed by further investigations.

Full text

PDF
218

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amlot P. L., Slaney J. M., Williams B. D. Circulating immune complexes and symptoms in Hodgkin's disease. Lancet. 1976 Feb 28;1(7957):449–451. doi: 10.1016/s0140-6736(76)91475-6. [DOI] [PubMed] [Google Scholar]
  2. Baldwin R. W., Price M. R., Robins R. A. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes. Nat New Biol. 1972 Aug 9;238(84):185–186. doi: 10.1038/newbio238185a0. [DOI] [PubMed] [Google Scholar]
  3. Baldwin R. W., Robins R. A. Humoral factors abrogating cell-mediated immunity in the tumor-bearing host. Curr Top Microbiol Immunol. 1975;72:21–53. doi: 10.1007/978-3-642-66289-8_2. [DOI] [PubMed] [Google Scholar]
  4. Heimer R., Klein G. Circulating immune complexes in sera of patients with Burkett's lymphoma and nasopharyngeal carcinoma. Int J Cancer. 1976 Sep 15;18(3):310–316. doi: 10.1002/ijc.2910180307. [DOI] [PubMed] [Google Scholar]
  5. Hellström I., Hellström K. E. Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms. Cancer. 1974 Oct;34(4 Suppl):suppl–suppl:1468. doi: 10.1002/1097-0142(197410)34:8+<1461::aid-cncr2820340818>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  6. Hellström I., Hellström K. E. Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas. Int J Cancer. 1969 Sep 15;4(5):587–600. doi: 10.1002/ijc.2910040503. [DOI] [PubMed] [Google Scholar]
  7. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  8. Heusser C., Boesman M., Nordin J. H., Isliker H. Effect of chemical and enzymatic radioiodination on in vitro human Clq activities. J Immunol. 1973 Mar;110(3):820–828. [PubMed] [Google Scholar]
  9. Jose D. G., Seshadri R. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity. Int J Cancer. 1974 Jun 15;13(6):824–838. doi: 10.1002/ijc.2910130610. [DOI] [PubMed] [Google Scholar]
  10. Kávai M., Berényi E., Pálkovi E., Szegedi G. Letter: Immune complexes in Hodgkin's disease. Lancet. 1976 Jun 5;1(7971):1249–1249. doi: 10.1016/s0140-6736(76)92209-1. [DOI] [PubMed] [Google Scholar]
  11. Mukojima T., Gunvén P., Klein G. Brief communication: circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt's lymphoma. J Natl Cancer Inst. 1973 Oct;51(4):1319–1321. doi: 10.1093/jnci/51.4.1319. [DOI] [PubMed] [Google Scholar]
  12. Nydegger U. E., Lambert P. H., Gerber H., Miescher P. A. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest. 1974 Aug;54(2):297–309. doi: 10.1172/JCI107765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sjögren H. O., Hellström I., Bansal S. C., Hellström K. E. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372–1375. doi: 10.1073/pnas.68.6.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Yonemasu K., Stroud R. M. Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies. J Immunol. 1971 Feb;106(2):304–313. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES